Compounds of the formula (I) ##STR00001## are useful as inhibitors of cGMP PDE especially Type 5.

 
Web www.patentalert.com

> Nucleic acid molecules encoding clot-specific streptokinase fusion proteins possessing altered plasminogen activation characteristics
~ 00323